{
  "id": "CVE-2002-2446",
  "sourceIdentifier": "cve@mitre.org",
  "published": "2015-08-04T14:59:02.877",
  "lastModified": "2025-04-12T10:46:40.837",
  "vulnStatus": "Deferred",
  "cveTags": [

  ],
  "descriptions": [
    {
      "lang": "en",
      "value": "GE Healthcare Millennium MG, NC, and MyoSIGHT has a password of insite.genieacq for the insite account that cannot be changed without disabling product functionality for remote InSite support, which has unspecified impact and attack vectors."
    },
    {
      "lang": "es",
      "value": "Vulnerabilidad en GE Healthcare Millennium MG, NC y MyoSIGHT, tiene una contrase√±a insite.genieacq para la cuenta de insite que no se puede cambiar sin deshabilitar la funcionalidad del producto para el soporte remoto de InSite, lo cual tiene un impacto y vectores de ataque no especificados."
    }
  ],
  "metrics": {
    "cvssMetricV2": [
      {
        "source": "nvd@nist.gov",
        "type": "Primary",
        "cvssData": {
          "version": "2.0",
          "vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
          "baseScore": 10.0,
          "accessVector": "NETWORK",
          "accessComplexity": "LOW",
          "authentication": "NONE",
          "confidentialityImpact": "COMPLETE",
          "integrityImpact": "COMPLETE",
          "availabilityImpact": "COMPLETE"
        },
        "baseSeverity": "HIGH",
        "exploitabilityScore": 10.0,
        "impactScore": 10.0,
        "acInsufInfo": true,
        "obtainAllPrivilege": false,
        "obtainUserPrivilege": false,
        "obtainOtherPrivilege": false,
        "userInteractionRequired": false
      }
    ]
  },
  "weaknesses": [
    {
      "source": "nvd@nist.gov",
      "type": "Primary",
      "description": [
        {
          "lang": "en",
          "value": "CWE-255"
        }
      ]
    }
  ],
  "configurations": [
    {
      "nodes": [
        {
          "operator": "OR",
          "negate": false,
          "cpeMatch": [
            {
              "vulnerable": true,
              "criteria": "cpe:2.3:o:gehealthcare:millennium_mg_firmware:-:*:*:*:*:*:*:*",
              "matchCriteriaId": "DD46362C-2338-4E63-8076-8E4A9FBC551F"
            },
            {
              "vulnerable": true,
              "criteria": "cpe:2.3:o:gehealthcare:millennium_myosight_firmware:-:*:*:*:*:*:*:*",
              "matchCriteriaId": "90FE8411-70AC-4C6B-9825-1015D04ADE27"
            },
            {
              "vulnerable": true,
              "criteria": "cpe:2.3:o:gehealthcare:millennium_nc_firmware:-:*:*:*:*:*:*:*",
              "matchCriteriaId": "C2286499-C442-4927-A070-19AD6D52314A"
            }
          ]
        }
      ]
    }
  ],
  "references": [
    {
      "url": "http://apps.gehealthcare.com/servlet/ClientServlet/2338955-100.pdf?REQ=RAA&DIRECTION=2338955-100&FILENAME=2338955-100.pdf&FILEREV=1&DOCREV_ORG=1",
      "source": "cve@mitre.org"
    },
    {
      "url": "http://apps.gehealthcare.com/servlet/ClientServlet/2354459-100.pdf?REQ=RAA&DIRECTION=2354459-100&FILENAME=2354459-100.pdf&FILEREV=4&DOCREV_ORG=4",
      "source": "cve@mitre.org"
    },
    {
      "url": "http://www.forbes.com/sites/thomasbrewster/2015/07/10/vulnerable-breasts/",
      "source": "cve@mitre.org"
    },
    {
      "url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02",
      "source": "cve@mitre.org"
    },
    {
      "url": "https://twitter.com/digitalbond/status/619250429751222277",
      "source": "cve@mitre.org"
    },
    {
      "url": "http://apps.gehealthcare.com/servlet/ClientServlet/2338955-100.pdf?REQ=RAA&DIRECTION=2338955-100&FILENAME=2338955-100.pdf&FILEREV=1&DOCREV_ORG=1",
      "source": "af854a3a-2127-422b-91ae-364da2661108"
    },
    {
      "url": "http://apps.gehealthcare.com/servlet/ClientServlet/2354459-100.pdf?REQ=RAA&DIRECTION=2354459-100&FILENAME=2354459-100.pdf&FILEREV=4&DOCREV_ORG=4",
      "source": "af854a3a-2127-422b-91ae-364da2661108"
    },
    {
      "url": "http://www.forbes.com/sites/thomasbrewster/2015/07/10/vulnerable-breasts/",
      "source": "af854a3a-2127-422b-91ae-364da2661108"
    },
    {
      "url": "https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02",
      "source": "af854a3a-2127-422b-91ae-364da2661108"
    },
    {
      "url": "https://twitter.com/digitalbond/status/619250429751222277",
      "source": "af854a3a-2127-422b-91ae-364da2661108"
    }
  ]
}